1. Anti-infection Apoptosis Autophagy NF-κB Metabolic Enzyme/Protease Immunology/Inflammation
  2. Bacterial Apoptosis Antibiotic Parasite Autophagy Reactive Oxygen Species
  3. Benzyl isothiocyanate

Benzyl isothiocyanate  (Synonyms: 苄基异硫氰酸酯)

目录号: HY-77813 纯度: 99.29%
COA 产品使用指南

Benzyl isothiocyanate 是一种口服有效的异硫氰酸酯,具有杀菌、抗癌、抗血管生成和驱虫活性。Benzyl isothiocyanate 通过调节细胞凋亡 (apoptosis)、细胞增殖、细胞周期阻滞、转移、血管生成、自噬 (autophagy) 等多种信号通路发挥抗癌功能。此外,Benzyl isothiocyanate 可以增强肌肉的胰岛素敏感性来改善肥胖引起的高血糖。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Benzyl isothiocyanate Chemical Structure

Benzyl isothiocyanate Chemical Structure

CAS No. : 622-78-6

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ¥550
In-stock
100 mg ¥500
In-stock
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Customer Review

Other Forms of Benzyl isothiocyanate:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Benzyl isothiocyanate is an orally available isothiocyanate with bactericidal, anticancer, antiangiogenic and anthelmintic activities. Benzyl isothiocyanate exerts anticancer functions by regulating multiple signaling pathways, including apoptosis, cell proliferation, cell cycle arrest, metastasis, angiogenesis, and autophagy. In addition, Benzyl isothiocyanate can enhance muscle insulin sensitivity to improve obesity-induced hyperglycemia[1][2][3][4][5][6][7][8][9].

细胞效力
(Cellular Effect)
Cell Line Type Value Description References
A549 IC50
20.5 μM
Compound: A
Antiproliferative activity against human A549 cells after 72 hrs by SRB assay
Antiproliferative activity against human A549 cells after 72 hrs by SRB assay
[PMID: 21704523]
Caco-2 IC50
15 μM
Compound: 1a, BITC
Cytotoxicity against human Caco-2 cells after 72 hrs by MTS assay
Cytotoxicity against human Caco-2 cells after 72 hrs by MTS assay
[PMID: 19053750]
HT-1080 IC50
> 50 μM
Compound: 1a, BITC
Cytotoxicity against human HT1080 cells after 72 hrs by MTS assay
Cytotoxicity against human HT1080 cells after 72 hrs by MTS assay
[PMID: 19053750]
LoVo IC50
10.5 μM
Compound: A
Antiproliferative activity against doxorubicin-resistant human LoVo cells after 72 hrs by SRB assay
Antiproliferative activity against doxorubicin-resistant human LoVo cells after 72 hrs by SRB assay
[PMID: 21704523]
LoVo IC50
12.3 μM
Compound: A
Antiproliferative activity against human LoVo cells after 72 hrs by SRB assay
Antiproliferative activity against human LoVo cells after 72 hrs by SRB assay
[PMID: 21704523]
LoVo IC50
14.5 μM
Compound: BITC
Antiproliferative activity against human LoVo cells after 72 hrs by SRB assay
Antiproliferative activity against human LoVo cells after 72 hrs by SRB assay
[PMID: 29945793]
LoVo IC50
14.5 μM
Compound: 26
Antiproliferative activity against human LoVo cells assessed as reduction in cell viability after 72 hrs by SRB assay
Antiproliferative activity against human LoVo cells assessed as reduction in cell viability after 72 hrs by SRB assay
[PMID: 26639764]
LoVo IC50
14.5 μM
Compound: BITC
Cytotoxicity against human LoVo cells after 72 hrs by sulforhodamine B assay
Cytotoxicity against human LoVo cells after 72 hrs by sulforhodamine B assay
[PMID: 28342398]
MCF7 IC50
18.9 μM
Compound: A
Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay
Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay
[PMID: 21704523]
MDA-MB-231 IC50
42 μM
Compound: 1a, BITC
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTS assay
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTS assay
[PMID: 19053750]
PC-3 IC50
> 50 μM
Compound: 1a, BITC
Cytotoxicity against human PC-3 cells after 72 hrs by MTS assay
Cytotoxicity against human PC-3 cells after 72 hrs by MTS assay
[PMID: 19053750]
T47D IC50
7.4 μM
Compound: A
Antiproliferative activity against human T47D cells after 72 hrs by SRB assay
Antiproliferative activity against human T47D cells after 72 hrs by SRB assay
[PMID: 21704523]
T98G IC50
> 100 μM
Compound: 1a, BITC
Cytotoxicity against human T98G cells after 72 hrs by MTS assay
Cytotoxicity against human T98G cells after 72 hrs by MTS assay
[PMID: 19053750]
UACC-903 IC50
15 μM
Compound: 1a, BITC
Cytotoxicity against human UACC-903 cells after 72 hrs by MTS assay
Cytotoxicity against human UACC-903 cells after 72 hrs by MTS assay
[PMID: 19053750]
体外研究
(In Vitro)

Benzyl isothiocyanate (1-5 µM; 24 和 48 h) 显著抑制 B16F10 细胞的迁移、迁移和侵袭性[2]
Benzyl isothiocyanate 对秀丽隐杆线虫具有一定的毒性,LC90 值在 15-45 µM 之间[5]
Benzyl isothiocyanate 对人卵巢肿瘤细胞系 CH1、41M 和 SKOV-3,小鼠白血病细胞系 L-1210 和小鼠实体瘤细胞系 PC6/sens 均有一定的细胞毒性,IC50 值分别为 2.2、7.2、6.1、2.0 和 2.2 µM[7]
Benzyl isothiocyanate 剂量依赖性地抑制 HeLa 细胞系的生长,IC50 值为 1.9 µM[7]
Benzyl isothiocyanate (5 μM; 16 h) 促进 PA 处理的 C2C12 肌管的胰岛素依赖性葡萄糖摄取, 上调 C2C12 肌管抗氧化防御并抑制 PA诱导的 ROS 生成[8]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[2]

Cell Line: B16F10 cells
Concentration: 1, 2.5 and 5 µM
Incubation Time: 24 and 48 h
Result: Increased the expression of MAPK signaling-related proteins and inhibited the expression of RhoA, Ras and sod-1.
体内研究
(In Vivo)

Benzyl isothiocyanate (饮食添加 0.05 % 和 0.1% BITC; p.o.; 18 周) 使饲喂 HFD 的 C57BL/6J 小鼠最终体重分别以剂量依赖性降低了 10 % 和 19.1 %[8]
Benzyl isothiocyanate (饲喂含有 100 ppm Benzyl isothiocyanate 的基础饲粮;p.o.;53 周) 降低雄性 ACI/N 大鼠体内 N-Nitrosodiethylamine (HY-N7434) 诱导的肝肿瘤发生率[9]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male ACI/N rats were injected intraperitoneally with a single dose of 200 mg/kg DEN before administration[9].
Dosage: 100 ppm
Administration: Mixed in the basic diet for daily feeding
Result: Reduce liver weight and relative liver weight in mice.
Animal Model: Male 4-week-old C57BL/6J mice fed a high-calorie diet[8]
Dosage: Add 0.05% or 0.1% BITC to high-calorie diets
Administration: Free feeding for 18 weeks
Result: Reduced plasma total cholesterol, non-esterified fatty acids, glucose levels and HOMA-IR in a dose-dependent manner.
分子量

149.21

Formula

C8H7NS

CAS 号
性状

液体(密度:1.125 g/cm3  )

颜色

Colorless to light yellow

中文名称

苄基异硫氰酸酯

结构分类
初始来源
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

溶解性数据
细胞实验: 

DMSO 中的溶解度 : 110 mg/mL (737.22 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

H2O 中的溶解度 : < 0.1 mg/mL (insoluble)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 6.7020 mL 33.5098 mL 67.0196 mL
5 mM 1.3404 mL 6.7020 mL 13.4039 mL
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (stored under nitrogen)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

动物实验:

请根据您的 实验动物和给药方式 选择适当的溶解方案。

以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用
以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 方案 一

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: 2.75 mg/mL (18.43 mM); 悬浊液; 超声助溶

    此方案可获得 2.75 mg/mL的均匀悬浊液,悬浊液可用于口服和腹腔注射。

    1 mL 工作液为例,取 100 μL 27.5 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;再向上述体系中加入 50 μL Tween-80,混合均匀;然后再继续加入 450 μL 生理盐水 定容至 1 mL

    生理盐水的配制:将 0.9 g 氯化钠,溶解于 ddH₂O 并定容至 100 mL,可以得到澄清透明的生理盐水溶液。
  • 方案 二

    请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: 2.75 mg/mL (18.43 mM); 悬浊液; 超声助溶

    此方案可获得 2.75 mg/mL的均匀悬浊液,悬浊液可用于口服和腹腔注射。

    1 mL 工作液为例,取 100 μL 27.5 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液 中,混合均匀。

    2 g SBE-β-CD(磺丁基醚 β-环糊精)粉末定容于 10 mL 的生理盐水中,完全溶解至澄清透明。
动物溶解方案计算器
请输入动物实验的基本信息:

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

由于实验过程有损耗,建议您多配一只动物的量
请输入您的动物体内配方组成:
%
DMSO +
+
%
Tween-80 +
%
Saline
如果您的动物是免疫缺陷鼠或者体弱鼠,建议 DMSO 中的在最后工作液体系中的占比尽量不超过 2%。
方案所需 助溶剂 包括:DMSO ,均可在 MCE 网站选购。 Tween 80,均可在 MCE 网站选购。
计算结果
工作液所需浓度 : mg/mL
储备液配制方法 : mg 药物溶于 μL  DMSO(母液浓度为 mg/mL)。

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

您所需的储备液浓度超过该产品的实测溶解度,以下方案仅供参考,如有需要,请与 MCE 中国技术支持联系。
动物实验体内工作液的配制方法 : 取 μL DMSO 储备液,加入 μL  μL ,混合均匀至澄清,再加 μL Tween 80,混合均匀至澄清,再加 μL 生理盐水
连续给药周期超过半月以上,请谨慎选择该方案。
请确保第一步储备液溶解至澄清状态,从左到右依次添加助溶剂。您可采用超声加热 (超声清洗仪,建议频次 20-40 kHz),涡旋吹打等方式辅助溶解。
纯度 & 产品资料
参考文献

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (stored under nitrogen)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 6.7020 mL 33.5098 mL 67.0196 mL 167.5491 mL
5 mM 1.3404 mL 6.7020 mL 13.4039 mL 33.5098 mL
10 mM 0.6702 mL 3.3510 mL 6.7020 mL 16.7549 mL
15 mM 0.4468 mL 2.2340 mL 4.4680 mL 11.1699 mL
20 mM 0.3351 mL 1.6755 mL 3.3510 mL 8.3775 mL
25 mM 0.2681 mL 1.3404 mL 2.6808 mL 6.7020 mL
30 mM 0.2234 mL 1.1170 mL 2.2340 mL 5.5850 mL
40 mM 0.1675 mL 0.8377 mL 1.6755 mL 4.1887 mL
50 mM 0.1340 mL 0.6702 mL 1.3404 mL 3.3510 mL
60 mM 0.1117 mL 0.5585 mL 1.1170 mL 2.7925 mL
80 mM 0.0838 mL 0.4189 mL 0.8377 mL 2.0944 mL
100 mM 0.0670 mL 0.3351 mL 0.6702 mL 1.6755 mL
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Benzyl isothiocyanate
目录号:
HY-77813
需求量: